148 related articles for article (PubMed ID: 37853958)
1. Sinonasal NUT carcinoma: A consecutive case series and systematic review.
Ramesh U; Contrera KJ; Shakibai N; Su SY; Brahimaj B; Roberts D; Williams MD; Ferrarotto R; Phan J; Gunn GB; Raza S; DeMonte F; Hanna EY
Head Neck; 2024 Jan; 46(1):29-36. PubMed ID: 37853958
[TBL] [Abstract][Full Text] [Related]
2. Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma.
Contrera KJ; Shakibai N; Su SY; Gule-Monroe MK; Roberts D; Brahimaj B; Williams MD; Ferrarotto R; Phan J; Gunn B; Raza S; DeMonte F; Hanna EY
Otolaryngol Head Neck Surg; 2023 Aug; 169(2):435-440. PubMed ID: 36856048
[TBL] [Abstract][Full Text] [Related]
3. Trimodality management of sinonasal undifferentiated carcinoma and review of the literature.
Mourad WF; Hauerstock D; Shourbaji RA; Hu KS; Culliney B; Li Z; Jacobson A; Tran T; Manolidis S; Schantz S; Urken M; Persky M; Harrison LB
Am J Clin Oncol; 2013 Dec; 36(6):584-8. PubMed ID: 22992621
[TBL] [Abstract][Full Text] [Related]
4. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
[TBL] [Abstract][Full Text] [Related]
5. NUT midline carcinomas of the sinonasal tract.
Bishop JA; Westra WH
Am J Surg Pathol; 2012 Aug; 36(8):1216-21. PubMed ID: 22534723
[TBL] [Abstract][Full Text] [Related]
6. Management of nonesthesioneuroblastoma sinonasal malignancies with neuroendocrine differentiation.
Fried D; Zanation AM; Huang B; Hayes N; Morris DE; Rosenman J; Varia M; Funkhouser W; Weissler M; Chera BS
Laryngoscope; 2012 Oct; 122(10):2210-5. PubMed ID: 22886723
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies.
Choi KY; Amit M; Tam S; Bell D; Phan J; Garden AS; Williams MD; Ferrarotto R; El-Naggar AK; Raza SM; DeMonte F; Kupferman ME; Hanna EY; Su SY
Laryngoscope; 2021 May; 131(5):E1468-E1475. PubMed ID: 32946597
[TBL] [Abstract][Full Text] [Related]
8. Impact of induction chemotherapy and socioeconomics on sinonasal undifferentiated carcinoma survival.
Lehrich BM; Goshtasbi K; Abiri A; Yasaka T; Sahyouni R; Papagiannopoulos P; Tajudeen BA; Kuan EC
Int Forum Allergy Rhinol; 2020 May; 10(5):679-688. PubMed ID: 32104985
[TBL] [Abstract][Full Text] [Related]
9. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma.
Kuo P; Manes RP; Schwam ZG; Judson BL
Otolaryngol Head Neck Surg; 2017 Jan; 156(1):132-136. PubMed ID: 27703092
[TBL] [Abstract][Full Text] [Related]
10. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.
Amit M; Abdelmeguid AS; Watcherporn T; Takahashi H; Tam S; Bell D; Ferrarotto R; Glisson B; Kupferman ME; Roberts DB; Su SY; Raza SM; DeMonte F; Hanna EY
J Clin Oncol; 2019 Feb; 37(6):504-512. PubMed ID: 30615549
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy.
van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB
Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993
[TBL] [Abstract][Full Text] [Related]
12. Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): A case-series, systematic review and meta-analysis.
Morand GB; Anderegg N; Vital D; Ikenberg K; Huber GF; Soyka MB; Egger M; Holzmann D
Oral Oncol; 2017 Dec; 75():28-34. PubMed ID: 29224819
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis.
Kang JH; Cho SH; Kim JP; Kang KM; Cho KS; Kim W; Seol YM; Lee S; Park HS; Hur WJ; Choi YJ; Oh SY
J Oral Maxillofac Surg; 2012 Jul; 70(7):1717-23. PubMed ID: 21945430
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognostic factors of sinonasal undifferentiated carcinoma: a multicenter study.
de Bonnecaze G; Verillaud B; Chaltiel L; Fierens S; Chapelier M; Rumeau C; Malard O; Gavid M; Dufour X; Righini C; Uro-Coste E; Rives M; Bach C; Baujat B; Janot F; de Gabory L; Vergez S
Int Forum Allergy Rhinol; 2018 Sep; 8(9):1065-1072. PubMed ID: 29935059
[TBL] [Abstract][Full Text] [Related]
15. A multimodality approach to sinonasal undifferentiated carcinoma: a single institute experience.
Bhasker S; Mallick S; Benson R; Bhanuprasad V; Sharma A; Thakar A
J Laryngol Otol; 2017 Jan; 131(1):19-25. PubMed ID: 27938440
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review.
Gray ST; Herr MW; Sethi RK; Diercks G; Lee L; Curry W; Chan A; Clark J; Holbrook EH; Rocco J; Sadow PM; Lin DT
Head Neck; 2015 Mar; 37(3):366-74. PubMed ID: 24421248
[TBL] [Abstract][Full Text] [Related]
17. Treatment Outcomes and Prognostic Factors of Adult Sinonasal Sarcomas: A Single-Institution Case Series.
Ding J; Wang C; Xiang J; Shen C; Hu C; Xu T; Lu X
Med Sci Monit; 2018 Sep; 24():6113-6118. PubMed ID: 30173244
[TBL] [Abstract][Full Text] [Related]
18. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase.
Mehta GU; Raza SM; Su SY; Hanna EY; DeMonte F
J Neurooncol; 2020 Dec; 150(3):367-375. PubMed ID: 32424573
[TBL] [Abstract][Full Text] [Related]
19. Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis.
Khademi B; Moradi A; Hoseini S; Mohammadianpanah M
Oral Maxillofac Surg; 2009 Dec; 13(4):191-9. PubMed ID: 19795137
[TBL] [Abstract][Full Text] [Related]
20. Clinical management of localized undifferentiated sinonasal carcinoma: our experience and review of the literature.
Perri F; Della Vittoria Scarpati G; Ionna F; Longo F; Montano M; Muto P; Ravo V; Giuliano M; Caponigro F
Anticancer Drugs; 2019 Mar; 30(3):308-312. PubMed ID: 30779722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
